Nodal peripheral T-cell lymphoma: a prognostic index developed by the T-cell project
To characterize real-world treatment patterns and outcomes in nodal peripheral T-cell lymphoma (PTCL) and to develop and externally validate a contemporary clinical prognostic model, we analyzed patients prospectively registered in the International T-Cell Project 2 (TCP2). Between January 2018 and January 2026, 1,465 patients with PTCL were registered; 959 with nodal PTCL by the 2016 WHO classification (PTCL not otherwise specified (PTCL-NOS), systemic anaplastic large-cell lymphoma (ALCL; ALK-positive or ALK-negative), and T-follicular helper lymphoma (TFHL)) were analyzed. The primary endpoint was 2-year progression-free survival (PFS); the model was externally validated in the TCP1 cohort (n = 1,016). The cohort comprised 396 PTCL-NOS (41%), 263 TFHL (27%), 211 ALK-negative ALCL (22%), and 89 ALK-positive ALCL (9%). First-line therapy was CHOEP in 340 (37%), CHOP in 260 (29%), and brentuximab vedotin-CHP in 139 (15%); 156 underwent consolidative stem cell transplantation. After a median follow-up of 25.3 months, 2-year PFS and overall survival were 35.3% and 54.3%, respectively. In multivariate analysis, diagnosis other than ALCL, age ≥65 years, ECOG performance status ≥2, thrombocytopenia, extranodal involvement, and elevated LDH were independently associated with inferior PFS. A six-variable score using these factors stratified patients into 3 risk groups - low (score 0-1), intermediate (2-3), and high (4-6) with 2-year PFS, 65%, 33%, and 16% respectively (P < .001) and was confirmed in the TCP1 validation cohort. Outcomes for nodal PTCL remain poor with current therapy; the externally validated TCP score offers a contemporary, complementary tool for risk stratification and identification of patients at high risk of treatment failure. ClinicalTrials.gov NCT03964480, NCT01142674.
Authors
- Yasodha Natkunam (ORCID: https://orcid.org/0000-0002-9816-1018)
- CARLOS SÉRGIO CHIATTONE (ORCID: https://orcid.org/0000-0002-4639-2578)
- Eliza Anne Hawkes (ORCID: https://orcid.org/0000-0002-0376-2559)
- Raimundo Gazitúa (ORCID: https://orcid.org/0000-0002-1269-7322)
- Danielle Leão Cordeiro de Farias (ORCID: https://orcid.org/0000-0002-3140-2235)
- Eliza Chung (ORCID: https://orcid.org/0000-0001-6642-1033)
- Thais Rodrigues da Cunha Fischer (ORCID: https://orcid.org/0000-0002-7547-2243)
- Henry Miles Prince (ORCID: https://orcid.org/0000-0002-0058-2448)
- Luana Conte (ORCID: https://orcid.org/0000-0002-8741-3478)
- Massimo Federico (ORCID: https://orcid.org/0000-0002-9889-3796)
- Fernando Warley (ORCID: https://orcid.org/0000-0002-2589-8190)
- Giorgio De Nunzio (ORCID: https://orcid.org/0000-0002-1998-0286)
- Nazar Shokun (ORCID: https://orcid.org/0009-0007-4294-2492)
- Iryna Kryachok
- Camila Peña (ORCID: https://orcid.org/0000-0002-8076-2077)
- Francine M. Foss (ORCID: https://orcid.org/0000-0001-7843-3162)
- K. Filonenko (ORCID: https://orcid.org/0000-0002-0725-3110)
- Lorena Fiad (ORCID: https://orcid.org/0000-0003-4816-7523)
- Iryna Tytorenko
- Carolina Valeria Mahuad (ORCID: https://orcid.org/0000-0002-3862-8122)
- Ranjana H. Advani (ORCID: https://orcid.org/0000-0002-3219-2292)
- Ilias Stagakis
- Julie Marie Vose (ORCID: https://orcid.org/0000-0003-1015-7434)
- Silvia Gambara (ORCID: https://orcid.org/0009-0004-0527-6089)
- Ciprian Tomuleasa (ORCID: https://orcid.org/0000-0001-5500-1519)
- Cameron J. Wellard (ORCID: https://orcid.org/0000-0002-6115-5394)
- Tetiana Skrypets (ORCID: https://orcid.org/0000-0002-2276-869X)
- Graciela Alfonso (ORCID: https://orcid.org/0000-0002-4143-5065)
- Stefano Luminari
- Neeraj Arora
- Won Seog Kim
- Sabina Ioana Doinita Iluta (ORCID: https://orcid.org/0009-0001-6537-325X)
Institutions
- University of Modena and Reggio Emilia (IT)
- University of Salento (IT)
- The University of Melbourne (AU)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Kantonsspital St. Gallen (CH)
- Santa Casa Hospital (BR)
- Peter MacCallum Cancer Centre (AU)
- Samsung Medical Center (KR)
- Hospital Italiano de Buenos Aires (AR)
- AC Camargo Hospital (BR)
- Yale University (US)
- Tata Medical Center (IN)
- Hospital del Salvador (CL)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Beneficência Portuguesa de São Paulo (BR)
- Hospital Italiano La Plata (AR)
- National Cancer Institute (UA)
- Fundación Arturo López Pérez (CL)
- Hospital Alemán (AR)
- Hospital Posadas (AR)
- Universidad Hospital Italiano (AR)
- Monash University (AU)
- University of Nebraska Medical Center (US)
- Sungkyunkwan University (KR)
- Stanford University (US)
Publication Details
- Journal
- Blood Advances
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1182/bloodadvances.2026021721
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00